No abstract available
Keywords:
neurodegeneration; neurodegenerative diseases; neuronal network dysfunction; neuronal network remodeling; neurotransmitter.
Grants and funding
We acknowledge funding support from the Alzheimer's New Zealand Charitable Trust (370836), Alzheimer's Zealand (3718869), and Freemasons New Zealand (3719321) to AK. AP was supported by the National Health and Medical Research Council to AP (APP1160412). FP-O was supported by Pappit-UNAM (IG200521) and by CONACyT (A1-S-7540).